CHIEDU OGWU: Open Payments
NPI 1669855250 · LANCASTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 37 payments from 14 companies in 2025. Trend: 2023 $734 · 2024 $712 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $274 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Lilly USA, LLC | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $39 |
| Corcept Therapeutics | 1 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
Products named: Ozempic, TRELEGY ELLIPTA, JARDIANCE, MOUNJARO, Rybelsus, Cologuard Collection Kit, FARXIGA, Wegovy.
Industry payments across TX — which companies pay providers there.
